Business Description
JanOne Inc
NAICS : 562998
SIC : 4953
ISIN : US03814F2056
Description
JanOne Inc is focused on being a clinical-stage pharmaceutical company committed to finding treatments for conditions that cause severe pain and bringing drugs to market with non-addictive pain-relieving properties. One of the Company's goals is to reduce the need for prescriptions for dangerous opioid drugs by treating underlying diseases that cause severe pain. The company operates in two operating segments, namely Biotechnology, and discontinued operations.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | -0.18 | |||||
| Debt-to-Equity | -0.21 | |||||
| Debt-to-EBITDA | -0.22 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 31.7 | |||||
| 3-Year EPS without NRI Growth Rate | 46.1 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 80.84 | |||||
| 9-Day RSI | 82.39 | |||||
| 14-Day RSI | 81.02 | |||||
| 6-1 Month Momentum % | 766.42 | |||||
| 12-1 Month Momentum % | 198.21 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.06 | |||||
| Quick Ratio | 0.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -39.4 | |||||
| Shareholder Yield % | 16.32 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -95.85 | |||||
| ROA % | -23.12 | |||||
| ROIC % | -12.94 | |||||
| ROC (Joel Greenblatt) % | -57.93 | |||||
| ROCE % | -18.23 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Price-to-Free-Cash-Flow | 8.72 | |||||
| Price-to-Operating-Cash-Flow | 8.72 | |||||
| EV-to-EBIT | -8.68 | |||||
| EV-to-EBITDA | -12.5 | |||||
| EV-to-FCF | 28.15 | |||||
| Earnings Yield (Greenblatt) % | -11.52 | |||||
| FCF Yield % | 3.61 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
JanOne Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -1.35 | ||
| Beta | 2.88 | ||
| Volatility % | 204.41 | ||
| 14-Day RSI | 81.02 | ||
| 14-Day ATR (€) | 0.184884 | ||
| 20-Day SMA (€) | 2.9865 | ||
| 12-1 Month Momentum % | 198.21 | ||
| 52-Week Range (€) | 0.244 - 4.4 | ||
| Shares Outstanding (Mil) | 8.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
JanOne Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
JanOne Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
JanOne Inc Frequently Asked Questions
What is JanOne Inc(FRA:5AR1)'s stock price today?
The current price of FRA:5AR1 is €4.24. The 52 week high of FRA:5AR1 is €4.40 and 52 week low is €0.24.
When is next earnings date of JanOne Inc(FRA:5AR1)?
The next earnings date of JanOne Inc(FRA:5AR1) is 2024-05-22 Est..
Does JanOne Inc(FRA:5AR1) pay dividends? If so, how much?
JanOne Inc(FRA:5AR1) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers